Anti-GP2 IgA: A biomarker for disease severity and/or cholangiocarcinoma in primary sclerosing cholangitis?

Research output: Contribution to journalArticle

2 Citations (Scopus)
Original languageEnglish (US)
JournalGut
DOIs
StateAccepted/In press - Sep 1 2016

Fingerprint

Bile Duct Neoplasms
Intrahepatic Bile Ducts
Sclerosing Cholangitis
Cholangiocarcinoma
Immunoglobulin A
Biomarkers
anti-IgA

ASJC Scopus subject areas

  • Medicine(all)
  • Gastroenterology

Cite this

@article{399c5e989ec84fc786cf5131ab73f939,
title = "Anti-GP2 IgA: A biomarker for disease severity and/or cholangiocarcinoma in primary sclerosing cholangitis?",
author = "Sumera Rizvi and Yang, {Ju Dong} and Gores, {Gregory James}",
year = "2016",
month = "9",
day = "1",
doi = "10.1136/gutjnl-2016-312492",
language = "English (US)",
journal = "Gut",
issn = "0017-5749",
publisher = "BMJ Publishing Group",

}

TY - JOUR

T1 - Anti-GP2 IgA

T2 - A biomarker for disease severity and/or cholangiocarcinoma in primary sclerosing cholangitis?

AU - Rizvi, Sumera

AU - Yang, Ju Dong

AU - Gores, Gregory James

PY - 2016/9/1

Y1 - 2016/9/1

UR - http://www.scopus.com/inward/record.url?scp=84984991263&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84984991263&partnerID=8YFLogxK

U2 - 10.1136/gutjnl-2016-312492

DO - 10.1136/gutjnl-2016-312492

M3 - Article

C2 - 27587361

AN - SCOPUS:84984991263

JO - Gut

JF - Gut

SN - 0017-5749

ER -